HealthTab to Integrate CONTOUR®NEXT Family of Blood Glucose Meters to Offer Deeper Diabetes Patient Insights Geography
COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology Psychedelics Investing
Jamieson Wellness Inc. Announces Date of Second Quarter 2023 Financial Results and Conference Call Life Science Investing
Opinion paper calls for clarity on the definition of "psychedelic-assisted therapy" using psilocybin Psychedelics Investing
